Drug Topics
OCTOBER 27, 2022
Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
PhRMA
OCTOBER 27, 2022
PhRMA is proud to announce the release of its first ever chart pack on health equity. This chart pack contains information on health equity in three sections: (1) A Snapshot of Health Disparities in America, (2) Inequities in Access to Screenings and Medicines Allow Health Disparities to Persist, and (3) PhRMA’s Commitment to Building a More Equitable Health Care System for All.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 27, 2022
The keynote address for the fall 2022 Total Pharmacy Solutions Summit looks at where independent pharmacy is and what needs to be done.
PharmaVoice
OCTOBER 27, 2022
Biogen and Eisai's new Alzheimer's drug is wowing investigators, and it might help the companies get past previous failures.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 27, 2022
Pharmacy revenue needs to diversify, so what's out there?
Pharmacy Times
OCTOBER 27, 2022
Although clinicians cited lack of time as a reason for not using patient-reported outcomes, patients with HIV viewed their use very positively.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
OCTOBER 27, 2022
Shasqi founder and CEO José Mejía Oneto on how the company’s approach could provide a more effective alternative to ADCs and other emerging cancer therapies.
Pharmacy Times
OCTOBER 27, 2022
Phase 2 APPLY-PNH trial shows positive results superiority vs anti-C5 treatment in adult patients with PNH with residual anemia despite prior therapy.
STAT
OCTOBER 27, 2022
As an oncologist and a leader at a national cancer organization, I’ve watched countless families celebrate the incredible news that their child has defeated a pediatric cancer. But I often don’t have the heart — at least not right away — to tell them what’s coming next: a lifetime of doctor’s visits, health issues, and stress, much of it related to the treatments that were used to ensure their child’s survival.
Pharmacy Times
OCTOBER 27, 2022
In a panel, pharmacy technicians across the world discuss the role of automation in United States, Portugal, and the United Kingdom.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 27, 2022
Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting treatments, one manufacturer has returned to the market — but is selling its medicine for 10 to 20 times the prices offered by the only other companies with available supplies. Over the past week, Areva Pharmaceuticals began marketing vials of fludarabine at a wholesale price of $2,736, a much steeper cost than the $272 charged for the same dosage by Fresenius Kabi and the $109 price
Pharmacy Times
OCTOBER 27, 2022
IMU-935 is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma/truncated.
The FDA Law Blog
OCTOBER 27, 2022
By Holly N. Brevig, Senior Regulatory Device and Biologics Exper & Richard A. Lewis, Senior Regulatory Device & Biologics Expert — FDA recently published the final guidance document “ Comparability Protocols for Postapproval Changes to the Chemistry, Manufacturing, and Controls Information in an NDA, ANDA, or BLA.” This final guidance provides recommendations to original applicants and holders of approved applications for human drugs and certain biological products on implementing chemi
STAT
OCTOBER 27, 2022
Sure, you’ve heard of CRISPR. But it’s 2022. The acronym you need to know now is ADARs. That stands for “adenosine deaminases acting on RNA.” Catchy it may not be. But this RNA-editing class of proteins, made by all multicellular organisms, is starting to have its moment in the bioengineering sun.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
OCTOBER 27, 2022
The concept of patient centricity has been a key talking point across the healthcare ecosystem for years. Having recognised the tangible benefits that their unique insights and experiences can bring to the table, decision-makers are increasingly seeking new opportunities to partner with patients across a product’s lifecycle. However, fostering lasting and meaningful partnerships is not a simple task for life science companies.
STAT
OCTOBER 27, 2022
Montana is signaling it might step away from an innovative way of setting the prices its public employee health plan pays hospitals for services, an approach that has saved the state millions of dollars and become a model for health plans nationwide. The plan gained national renown among employers and health care price reform advocates when, in 2016, it established maximum amounts the health plan would pay for all inpatient and outpatient services.
Drug Store News
OCTOBER 27, 2022
Doug Long discussed where we are with COVID-19, cough, cold and flu, and RSV, medical claims, telehealth, channels of trade, generics, biosimilars and opioids.
STAT
OCTOBER 27, 2022
WASHINGTON — Democrats are suddenly blasting Republicans on the campaign trail over a surprising new topic: their plans to reform Medicare. Touching any kind of entitlement spending is generally unpopular with voters, particularly ahead of a midterm election. Republicans’ official campaign platform provides scant detail about the issue, beyond a vague promise to “save and strengthen” Medicare and ensure its financial solvency.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
OCTOBER 27, 2022
Beautify.Tips was designed to help beauty lovers stay up to date on the latest tips, tricks and trends.
DiversifyRx
OCTOBER 27, 2022
Many pharmacy owners will need a source of working capital at some point in their ownership journey. Pharmacy Cash Flow Is Tight. Recently we put up a poll on our LinkedIn and Facebook pages, asking pharmacy owners if they were interested in learning about financing working capital. The overwhelming response was YES, as many pharmacy owners are dealing with tight cash flow, increased costs, etc.
ISPE
OCTOBER 27, 2022
Oligonucleotides: A Cornerstone for Therapeutics & More. Trudy Patterson. Thu, 10/27/2022 - 14:16. Features. November / December 2022. Oligonucleotides: A Cornerstone for Therapeutics & More. Brendan Nichols. 1 November 2022. Resounding clinical successes and maturation of extensive therapeutic pipelines have catapulted oligonucleotides from a fringe modality to therapeutic relevance in just a few short years.
European Pharmaceutical Review
OCTOBER 27, 2022
Elements leading to a rational design of cyclodextrin-based formulations. Cyclodextrins are a frequently used excipient in the pharmaceutical industry, employed in multiple dosage forms and with multiple purposes simply because of their numerous positive properties, including being generally well tolerated and safe. In this short article, René Holm, Professor in pharmaceutical physical chemistry at the University of Southern Denmark, provides a few examples of how a rational formulation design f
pharmaphorum
OCTOBER 27, 2022
Santhera has completed a rolling application for its Duchenne muscular dystrophy (DMD) therapy vamorolone in the US, setting up a possible approval and launch in the latter half of 2023. The Swiss biotech is seeking a priority review for vamorolone, which was licensed from US biotech ReveraGen BioPharma in 2020 after Santhera its former DMD therapy candidate idebenone failed clinical testing and was abandoned.
Drug Store News
OCTOBER 27, 2022
The Dunkin’ Box O’ Chocolates features two Hot Chocolate Bomb varieties and 12 individually wrapped donut-shaped filled chocolates.
pharmaphorum
OCTOBER 27, 2022
On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry ( IFPMA , the International Federation of Pharmaceutical Manufacturers and Associations, and EFPIA , the European Federation of Pharmaceutical Industries and Associations) published a Note for Guidance to assist member companies with their use of social media and digital channels and to help ensure they stay within the regulations on promotion of medicines to the public.
Drug Store News
OCTOBER 27, 2022
A strategic partnership with CorePharma expands Upsher-Smith’s portfolio.
pharmaphorum
OCTOBER 27, 2022
GSK has said it will not be able to move ahead with regulatory filings for otilimab as a treatment for rheumatoid arthritis (RA), after it failed to show the desired level of efficacy in two phase 3 trials. The phase 3 clinical programme, named ContRAst, was the first in RA to include head-to-head comparisons of otilimab with current treatments, hoping to build a niche for otilimab among hard-to-treat patients who have an inadequate response to or cannot tolerate available drugs.
Drug Store News
OCTOBER 27, 2022
Albertsons’ pet offerings provide pharmacy services and pilot healthcare programs to enhance convenience and reduce the financial burden associated with caring for four-legged family members.
Pharmacy Times
OCTOBER 27, 2022
An expert panel led by moderator Dr. Cunningham identify substance use disorder, COVID-19’s role, and opportunities for pharmacists to help patients with resources for recovery.
Pharma Times
OCTOBER 27, 2022
UK only places 11th in terms of total R&D investment as a percentage of GDP
Pharmacy Times
OCTOBER 27, 2022
Completing a breast cancer-focused continuing education credit and encouraging screenings are 2 ways that pharmacists can get involved during the month of October.
Pharma Times
OCTOBER 27, 2022
Study involves patients with advanced common cancers and solid tumours
Pharmacy Times
OCTOBER 27, 2022
Company takes another significant step to create a differentiated working environment.
Expert insights. Personalized for you.
503 
Let's personalize your content